NanoViricides(NNVC)
![icon](https://files.reportify.cn/fe-static/_next/static/media/search.b3fd6117.png?imageMogr2/quality/75/thumbnail/64x/format/webp)
Search documents
NanoViricides(NNVC) - 2024 Q4 - Annual Report
2024-09-27 20:15
Table of Contents | --- | --- | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
NanoViricides expands antiviral drug pipeline with TheraCour Pharma agreement
Proactiveinvestors NA· 2024-09-26 12:44
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...
NanoViricides CEO talks lead drug asset's potential as MPOX therapy - ICYMI
Proactiveinvestors NA· 2024-09-14 15:30
NanoViricides (NYSE-A:NNVC) CEO Anil Diwan joined Proactive to discuss the promise of its lead drug NV387 as a broad-spectrum antiviral. Diwan explained that NV-387, a host mimetic drug, works differently from traditional antiviral treatments by mimicking a natural cellular feature, making it difficult for viruses to escape. He highlighted successful preclinical and early clinical results, noting the drug's effectiveness against viruses like RSV, influenza, and more recently, monkeypox (MPOX). Proactive: Re ...
NanoViricides exploring emergency protocol to evaluate NV-387 for MPOX
Proactiveinvestors NA· 2024-08-26 12:51
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...
NanoViricides prepares for Phase II trial of broad-spectrum antiviral NV-387
Proactiveinvestors NA· 2024-08-19 12:48
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government. S ...
NanoViricides reports major progress in advancing broad-spectrum antiviral drug NV-387
Proactiveinvestors NA· 2024-08-08 12:37
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...
Can Nanotechnology offer Better Solutions for COVID, RSV and other Viruses?
Newsfile· 2024-08-02 11:00
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - August 2, 2024) - Investorideas.com, a go-to investing platform covering biotech and nanotechnology issues a snapshot looking at news and developments in the antiviral market, featuring NanoViricides, Inc. (NYSE American: NNVC), a development stage company that is creating special purpose nanomaterials for antiviral therapy. Read the full article on Investorideas.com https://www.investorideas.com/News/2024/nanotech/08020Better-Solutions-for- ...
NanoViricides' lead asset for broad spectrum efficacy wins praise in industry reports
Proactiveinvestors NA· 2024-08-01 12:46
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...
NanoViricides spotlights lead drug candidate's potential as COVID therapy
Proactiveinvestors NA· 2024-07-24 13:09
About this content About the publisher Proactive news team spans the world's key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth. Use of technology Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows. About Emily Jarvie Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable ...
NanoViricides discusses lead program and next steps
Proactiveinvestors NA· 2024-07-11 13:02
Proactive leads the world in up-to-the-minute, multi-media news provision, events organisation, investor relations management and investor research Read more Proactive has always been a forward looking and enthusiastic technology adopter. About this content About the publisher Proactive news team spans the world's key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth. The team delivers news and unique insights across the market including but not co ...